SpectraScience, Inc.
Save
Overview
Dividend safety
Dividends
Fundamentals

Create a free account to get access to stock details and our dividend tracker

We won't send you any spam and we don't want a credit card.

223
Market cap
Current P/E
Forward P/E
Dividend yield

About stock

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps.

Similar stocks

Based on sector and market capitalization

Report issue